If you are wondering whether Revolution Medicines at around US$120 per share reflects its real worth, you are not alone. This article is designed to help you frame that question clearly.
The stock closed at US$120.28 recently, with returns of 1.4% over 7 days, 52.7% over 30 days, 52.2% year to date, 198.5% over 1 year and 337.1% over 3 years, which naturally raises questions about how expectations and risk are being priced in.
Recent news flow around Revolution Medicines has focused on its role in pharmaceuticals and biotech. This helps explain why investors are paying close attention to its pipeline, partnerships and funding position. These themes form an important backdrop for understanding why the share price sits where it does…
